Do Cutaneous Neurofibromas Turn Into Cancer?
At a Glance
Cutaneous neurofibromas—the small, soft skin bumps common in Neurofibromatosis type 1 (NF1)—are completely benign and do not turn into cancer. However, deeper tumors called plexiform neurofibromas do carry an 8% to 13% lifetime risk of becoming cancerous and should be carefully monitored.
The short answer is no. The small, soft bumps on the surface of your skin—known medically as cutaneous neurofibromas—are benign (non-cancerous) and do not turn into cancer [1]. Because these skin tumors are highly visible and can grow in large numbers, it is incredibly common for people with Neurofibromatosis type 1 (NF1) to worry about them becoming dangerous. However, while they can be itchy, uncomfortable, or cosmetically distressing, cutaneous neurofibromas are strictly a surface-level skin issue and do not have a risk of malignant transformation [1].
While they will not turn into cancer, cutaneous neurofibromas can take a heavy emotional toll. If specific bumps are causing you physical discomfort or significant cosmetic anxiety, a dermatologist or NF specialist can often remove them through minor surgical procedures [2].
Understanding the Difference: Cutaneous vs. Plexiform
To understand your actual cancer risk in NF1, it is essential to know the strict difference between cutaneous neurofibromas and plexiform neurofibromas.
- Cutaneous Neurofibromas (cNF): These grow on or just beneath the surface of the skin. They move easily when you touch them, are usually soft, and, most importantly, they stay benign [1].
- Plexiform Neurofibromas (pNF): These tumors grow deeper inside the body and involve larger nerve branches [3]. They are often present at birth, though they might not be noticed until later. They can sometimes feel like a thick cord or a “bag of worms” under the skin, or they may be completely invisible from the outside and only found on scans [3].
Unlike the superficial skin bumps, plexiform neurofibromas do carry a risk of turning into cancer [4]. Research shows that people with NF1 have an 8% to 13% lifetime risk of a deep plexiform tumor transforming into an aggressive cancer known as a Malignant Peripheral Nerve Sheath Tumor (MPNST) [5].
While that statistic is frightening, it is important to know that not everyone with NF1 has a plexiform tumor (they occur in up to half of patients) [6]. If you are ever unsure whether a lump is just a harmless surface bump or a deeper plexiform tumor pushing up, ask your doctor to evaluate it.
What to Watch For
Because deep plexiform tumors can change, monitoring them is a critical part of your routine NF1 care. While you do not need to worry about your surface-level cutaneous bumps turning into cancer, you should be vigilant about deeper lumps.
Contact your doctor if you notice any of the following changes in a deeper tumor:
- Rapid growth: A tumor that suddenly gets noticeably larger [4].
- New or unmanageable pain: Pain that wakes you up at night, doesn’t go away, or feels different than your normal baseline [4].
- Change in texture: A lump that previously felt soft but suddenly becomes firm or hard [4].
- New weakness or numbness: Changes in how your muscles function or how you feel sensations in the area around a tumor [4].
Your care team can use advanced imaging, such as a Whole-Body MRI (WBMRI) or PET scans, to establish a baseline of any hidden internal tumors and evaluate suspicious changes [7][8]. This ensures that if a tumor does become malignant, it is caught as early as possible to provide the best treatment options [7].
Common questions in this guide
Can the small bumps on my skin from NF1 turn into cancer?
What is the difference between a cutaneous and a plexiform neurofibroma?
What are the warning signs that a deep tumor is turning into cancer?
How do doctors check for hidden deep tumors?
Can I get my cutaneous neurofibromas removed?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Do I have any known plexiform neurofibromas that we should be monitoring?
- 2.Would a baseline whole-body MRI be appropriate for me to check for hidden deep tumors?
- 3.If I find a lump and I'm not sure if it's a surface cutaneous bump or a deeper plexiform tumor, what is the best way to get it evaluated?
- 4.What specific symptoms or changes in my existing tumors should prompt me to call your office immediately, rather than waiting for my next appointment?
- 5.Can you refer me to a dermatologist who has experience removing cutaneous neurofibromas for cosmetic and comfort reasons?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (8)
- 1
A giant posterior mediastinal malignant peripheral nerve sheath tumor and benign neurofibroma in body surface: a case report.
Zhang Y, Cai H, Lv G, Li Y
BMC surgery 2021; (21(1)):128 doi:10.1186/s12893-021-01122-5.
PMID: 33691671 - 2
Do juxtaposed compound nevus and neurofibroma with melanocytic differentiation share an identical cell of origin in NF1?
Harder A, Tippmar M, Baschinskij S, et al.
European journal of dermatology : EJD 2015; (25(6)):615-7 doi:10.1684/ejd.2015.2643.
PMID: 26463573 - 3
Peripheral Nerve Sheath Tumors in Patients With Neurofibromatosis Type 1: Morphological and Immunohistochemical Study.
Friedrich RE, Nörnberg LKN, Hagel C
Anticancer research 2022; (42(3)):1247-1261 doi:10.21873/anticanres.15592.
PMID: 35220215 - 4
Cdkn2a Loss in a Model of Neurofibroma Demonstrates Stepwise Tumor Progression to Atypical Neurofibroma and MPNST.
Chaney KE, Perrino MR, Kershner LJ, et al.
Cancer research 2020; (80(21)):4720-4730 doi:10.1158/0008-5472.CAN-19-1429.
PMID: 32816910 - 5
Imaging findings of type I neurofibromatosis with outcome of malignant peripheral nerve sheath tumor in the right lower extremity.
Liu WH, Yang L, Wang XY, et al.
Journal of clinical ultrasound : JCU 2024; (52(9)):1450-1452 doi:10.1002/jcu.23807.
PMID: 39198889 - 6
Clinical features and disease severity in patients with mosaic neurofibromatosis type 1: a single-center study and literature review.
Ejerskov C, Raundahl M, Gregersen PA, Handrup MM
Orphanet journal of rare diseases 2021; (16(1)):180 doi:10.1186/s13023-021-01796-3.
PMID: 33853649 - 7
The value of 18F-FDG PET/CT in patient with neurofibromatosis type 1: A case report and literature review.
Ren J, Yang G, Zhou J, Fu Z
Medicine 2018; (97(20)):e10648 doi:10.1097/MD.0000000000010648.
PMID: 29768331 - 8
Imaging diagnosis of plexiform neurofibroma- unravelling the confounding features: A report of two cases.
Grover DSB, Kundra DR, Grover DH, et al.
Radiology case reports 2021; (16(9)):2824-2833 doi:10.1016/j.radcr.2021.06.025.
PMID: 34386146
This page provides educational information about neurofibromas and cancer risk. Always consult your NF specialist or dermatologist to evaluate any new or changing lumps to ensure proper diagnosis and care.
Get notified when new evidence is published on Neurofibromatosis type 1.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.